Unichem Laboratories Q3: Net profit jumps 5x to ₹264 crore despite lower revenue, EBITDA

Unichem Laboratories Ltd on Thursday (February 5) reported a net profit of ₹264.3 crore for the third quarter, compared with ₹58 crore in the year-ago period. Revenue for the quarter declined 2.2% year-on-year to ₹521.2 crore, against ₹533 crore in the corresponding quarter last year.

EBITDA for the quarter stood at ₹45 crore, down 47.4% from ₹85.4 crore reported in the same quarter last year. EBITDA margin came in at 8.6% for the quarter, compared with 16% in the year-ago period.

Also, the board has approved the appointment of Dr Swati Patankar as a Non-Executive Independent Director for a term of five consecutive years with effect from February 5, 2026, subject to approval of the shareholders.

Also Read: Unichem Labs’ Kolhapur API facility inspected by USFDA; 5 procedural observations

Dr Patankar will serve as an Independent Director from February 5, 2026, to February 4, 2031. She has more than 35 years of experience. She holds a B.Sc. (Hons) from St. Xavier’s College, Mumbai, and a PhD in Molecular Microbiology from Tufts University, Boston, USA.

Dr Patankar is a Professor in the Department of Biosciences and Bioengineering at IIT Bombay. She has served as Dean (International Relations) and as a member of the Board of Governors at IIT Bombay, gaining administrative experience across multiple domains.

Shares of Unichem Laboratories Ltd ended at ₹423.00, up by ₹5.35, or 1.28%, on the BSE.

Also Read: Unichem Labs gets €19.5-million demand notice from European Commission in patent dispute case